UncategorizedOligomerix secures US$0.5 million NIH SBIR Fast-Track grant for Alzheimer’s tau therapeutic – Longevity.Technology Empower Meds / November 20, 2025
UncategorizedEyePoint receives DSMC green light for pivotal Phase 3 DURAVYU trials in wet AMD – Longevity.Technology Empower Meds / November 20, 2025
UncategorizedMitophagy-promoting Parkinson’s drug funded into clinical trials Empower Meds / November 19, 2025
UncategorizedAnnovis Bio plans FDA meeting for PDD and confirms Phase 3 alignment for Alzheimer’s – Longevity.Technology Empower Meds / November 19, 2025
UncategorizedZymo Research and biomodal partner to offer advanced multi-omic sequencing – Longevity.Technology Empower Meds / November 19, 2025
UncategorizedOchre Bio completes human liver functional genomics datasets with GSK – Longevity.Technology Empower Meds / November 19, 2025
